Cargando…
Total Hip Arthroplasty Patients with Distinct Postoperative Fibrinolytic Phenotypes Require Different Antifibrinolytic Strategies
Bleeding patients exhibit different fibrinolytic phenotypes after injury, and the universal use of tranexamic acid (TXA) is doubted. We aimed to evaluate the efficacy of postoperative antifibrinolytic treatment in total hip arthroplasty (THA) patients with different fibrinolytic phenotypes. A retros...
Autores principales: | Liu, Jiacheng, Chen, Bowen, Wu, Xiangdong, Wang, Han, Zuo, Xiaohai, Lei, Yiting, Huang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736050/ https://www.ncbi.nlm.nih.gov/pubmed/36498472 http://dx.doi.org/10.3390/jcm11236897 |
Ejemplares similares
-
Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty
por: Liu, Jiacheng, et al.
Publicado: (2022) -
Antifibrinolytics
por: Székely, A, et al.
Publicado: (2014) -
Effectiveness and safety of the use of antifibrinolytic agents in total-knee arthroplasty: A meta-analysis
por: Ma, Qi-ming, et al.
Publicado: (2020) -
Antifibrinolytics in liver surgery
por: Makwana, Jalpa, et al.
Publicado: (2010) -
Antifibrinolytic Agents in Traumatic Haemorrhage
por: Coats, Tim, et al.
Publicado: (2005)